Nkarta’s (NKTX) Making  Promising Progress in Its Clinical-Stage Journey
PremiumMarket NewsNkarta’s (NKTX) Making Promising Progress in Its Clinical-Stage Journey
3M ago
Nkarta initiates trial of NKX019 in lupus erythematosus
Premium
The Fly
Nkarta initiates trial of NKX019 in lupus erythematosus
3M ago
Nkarta Announces New President and Strategic Executive Shifts
Premium
Company Announcements
Nkarta Announces New President and Strategic Executive Shifts
4M ago
Nkarta’s Annual Meeting Results in Key Corporate Decisions
PremiumCompany AnnouncementsNkarta’s Annual Meeting Results in Key Corporate Decisions
5M ago
Nkarta price target lowered to $15 from $16 at Canaccord
Premium
The Fly
Nkarta price target lowered to $15 from $16 at Canaccord
6M ago
Nkarta reports Q1 EPS (58c), consensus (56c)
Premium
The Fly
Nkarta reports Q1 EPS (58c), consensus (56c)
6M ago
Nkarta’s NKX019 Shows Potential in Lymphoma Treatment
PremiumCompany AnnouncementsNkarta’s NKX019 Shows Potential in Lymphoma Treatment
7M ago
Nkarta trading resumes
Premium
The Fly
Nkarta trading resumes
8M ago
Nkarta trading halted, volatility trading pause
Premium
The Fly
Nkarta trading halted, volatility trading pause
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100